This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

CALGB 140503 Results—An Interview with Nasser Altorki

Tuesday, August 23, 2022

Professor Nasser Altorki and his colleagues recently released the results of the landmark thoracic surgery trial, CALGB 140503. The randomized trial studied the different methods of thoracic surgery and how they perform in treating patients with stage IA non-small cell lung cancer (NSCLC). Ultimately, the trial results revealed that, with better surgical methods and technologies, sublobar resection may challenge the preexisting standard of lobar resection procedures in treating NSCLC.

CTSNet associate editors Joel Dunning and Mara Antonoff sat down with Dr. Altorki to discuss the trial and its implications for the thoracic specialty. Watch the interview below to learn more.



The information and views presented on represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.


Add comment

Log in or register to post comments